UNLABELLED: Very low-density lipoprotein (VLDL) secretion provides a mechanism to export triglycerides (TG) from the liver to peripheral tissues, maintaining lipid homeostasis. In nonalcoholic fatty liver disease (NAFLD), VLDL secretion disturbances are unclear. Methionine adenosyltransferase (MAT) is responsible for S-adenosylmethionine (SAMe) synthesis and MAT I and III are the products of the MAT1A gene. Deficient MAT I and III activities and SAMe content in the liver have been associated with NAFLD, but whether MAT1A is required for normal VLDL assembly remains unknown. We investigated the role of MAT1A on VLDL assembly in two metabolic contexts: in 3-month-old MAT1A-knockout mice (3-KO), with no signs of liver injury, and in 8-month-old MAT1A-knockout mice (8-KO), harboring nonalcoholic steatohepatitis. In 3-KO mouse liver, there is a potent effect of MAT1A deletion on lipid handling, decreasing mobilization of TG stores, TG secretion in VLDL and phosphatidylcholine synthesis via phosphatidylethanolamine N-methyltransferase. MAT1A deletion also increased VLDL-apolipoprotein B secretion, leading to small, lipid-poor VLDL particles. Administration of SAMe to 3-KO mice for 7 days recovered crucial altered processes in VLDL assembly and features of the secreted lipoproteins. The unfolded protein response was activated in 8-KO mouse liver, in which TG accumulated and the phosphatidylcholine-to-phosphatidylethanolamine ratio was reduced in the endoplasmic reticulum, whereas secretion of TG and apolipoprotein B in VLDL was increased and the VLDL physical characteristics resembled that in 3-KO mice. MAT1A deletion also altered plasma lipid homeostasis, with an increase in lipid transport in low-density lipoprotein subclasses and decrease in high-density lipoprotein subclasses. CONCLUSION: MAT1A is required for normal VLDL assembly and plasma lipid homeostasis in mice. Impaired VLDL synthesis, mainly due to SAMe deficiency, contributes to NAFLD development in MAT1A-KO mice.
UNLABELLED: Very low-density lipoprotein (VLDL) secretion provides a mechanism to export triglycerides (TG) from the liver to peripheral tissues, maintaining lipid homeostasis. In nonalcoholic fatty liver disease (NAFLD), VLDL secretion disturbances are unclear. Methionine adenosyltransferase (MAT) is responsible for S-adenosylmethionine (SAMe) synthesis and MAT I and III are the products of the MAT1A gene. Deficient MAT I and III activities and SAMe content in the liver have been associated with NAFLD, but whether MAT1A is required for normal VLDL assembly remains unknown. We investigated the role of MAT1A on VLDL assembly in two metabolic contexts: in 3-month-old MAT1A-knockout mice (3-KO), with no signs of liver injury, and in 8-month-old MAT1A-knockout mice (8-KO), harboring nonalcoholic steatohepatitis. In 3-KO mouse liver, there is a potent effect of MAT1A deletion on lipid handling, decreasing mobilization of TG stores, TG secretion in VLDL and phosphatidylcholine synthesis via phosphatidylethanolamine N-methyltransferase. MAT1A deletion also increased VLDL-apolipoprotein B secretion, leading to small, lipid-poor VLDL particles. Administration of SAMe to 3-KO mice for 7 days recovered crucial altered processes in VLDL assembly and features of the secreted lipoproteins. The unfolded protein response was activated in 8-KO mouse liver, in which TG accumulated and the phosphatidylcholine-to-phosphatidylethanolamine ratio was reduced in the endoplasmic reticulum, whereas secretion of TG and apolipoprotein B in VLDL was increased and the VLDL physical characteristics resembled that in 3-KO mice. MAT1A deletion also altered plasma lipid homeostasis, with an increase in lipid transport in low-density lipoprotein subclasses and decrease in high-density lipoprotein subclasses. CONCLUSION:MAT1A is required for normal VLDL assembly and plasma lipid homeostasis in mice. Impaired VLDL synthesis, mainly due to SAMe deficiency, contributes to NAFLD development in MAT1A-KO mice.
Authors: Maria Lauda Tomasi; Komal Ramani; Fernando Lopitz-Otsoa; Manuel S Rodríguez; Tony W H Li; Kwangsuk Ko; Heping Yang; Fawzia Bardag-Gorce; Ainhoa Iglesias-Ara; Francesco Feo; Maria Rosa Pascale; José M Mato; Shelly C Lu Journal: Hepatology Date: 2010-06 Impact factor: 17.425
Authors: Kaori Minehira; Stephen G Young; Claudio J Villanueva; Laxman Yetukuri; Matej Oresic; Mark K Hellerstein; Robert V Farese; Jay D Horton; Frederic Preitner; Bernard Thorens; Luc Tappy Journal: J Lipid Res Date: 2008-06-01 Impact factor: 5.922
Authors: Franck Rencurel; Marc Foretz; Michel R Kaufmann; Deborah Stroka; Renate Looser; Isabelle Leclerc; Gabriela da Silva Xavier; Guy A Rutter; Benoit Viollet; Urs A Meyer Journal: Mol Pharmacol Date: 2006-09-20 Impact factor: 4.436
Authors: Susan K Murphy; Hyuna Yang; Cynthia A Moylan; Herbert Pang; Andrew Dellinger; Manal F Abdelmalek; Melanie E Garrett; Allison Ashley-Koch; Ayako Suzuki; Hans L Tillmann; Michael A Hauser; Anna Mae Diehl Journal: Gastroenterology Date: 2013-07-31 Impact factor: 22.682
Authors: Sungwoo Choi; Bingning Dong; Chih-Chun Janet Lin; Mi Jeong Heo; Kang Ho Kim; Zhen Sun; Martin Wagner; Nagireddy Putluri; Jae Myoung Suh; Meng C Wang; David D Moore Journal: Hepatology Date: 2019-12-23 Impact factor: 17.425
Authors: Cristina Alonso; David Fernández-Ramos; Marta Varela-Rey; Ibon Martínez-Arranz; Nicolás Navasa; Sebastiaan M Van Liempd; José L Lavín Trueba; Rebeca Mayo; Concetta P Ilisso; Virginia G de Juan; Marta Iruarrizaga-Lejarreta; Laura delaCruz-Villar; Itziar Mincholé; Aaron Robinson; Javier Crespo; Antonio Martín-Duce; Manuel Romero-Gómez; Holger Sann; Julian Platon; Jennifer Van Eyk; Patricia Aspichueta; Mazen Noureddin; Juan M Falcón-Pérez; Juan Anguita; Ana M Aransay; María Luz Martínez-Chantar; Shelly C Lu; José M Mato Journal: Gastroenterology Date: 2017-01-26 Impact factor: 22.682
Authors: Maite Martínez-Uña; Marta Varela-Rey; Daniela Mestre; Larraitz Fernández-Ares; Olatz Fresnedo; David Fernandez-Ramos; Virginia Gutiérrez-de Juan; Idoia Martin-Guerrero; Africa García-Orad; Zigmund Luka; Conrad Wagner; Shelly C Lu; Carmelo García-Monzón; Richard H Finnell; Igor Aurrekoetxea; Xabier Buqué; M Luz Martínez-Chantar; José M Mato; Patricia Aspichueta Journal: J Hepatol Date: 2014-10-18 Impact factor: 25.083